期刊文献+

肾衰患者血浆同型半胱氨酸与心衰指数关系的探讨 被引量:2

原文传递
导出
摘要 该文探讨肾衰患者血浆同型半胱氨酸(Hcy)与心衰指数(HFI)间关系。笔者用荧光偏振免疫法测定Hcy。结果表明肾衰者无心衰组、可疑心衰组、心衰组Hcy 3组间差异有统计学意义,Hcy与HFI呈显著正相关,认为是导致早期心力衰竭的一个重要因素。
出处 《中国医师杂志》 CAS 2006年第1期86-87,共2页 Journal of Chinese Physician
  • 相关文献

参考文献4

  • 1Al-Ahmad A,Sarnak MJ,Salem DN,et al.Cause and management of heart failure in patients with chronic renal disease.Semin Nephol,2001,21(1):3-12.
  • 2陈国伟 郑宗锷.现代心脏内科学[M].长沙:湖南科学技术出版社,1998.1119-1127.
  • 3余月明,侯凡凡,张训,刘俊,胡敏燕,杨凌,许顶立.慢性肾功能衰竭患者的高同型半胱氨酸血症[J].中华肾脏病杂志,2002,18(1):34-37. 被引量:45
  • 4Koulouridis E,Tzilianos M,Katsarou A,et al.Homocysteine and C-reactive protein levels in patients.Int Urol Nephrol,2001,33(2):207-215.

二级参考文献13

  • 1Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem, 1994, 40:873-881.
  • 2Jacobsen DW. Cardiovascular disorders (risk assessment) . Clin Chem, 1993, 65: 367R-373R.
  • 3Yeun JY. The role of homocysteine in end - stage renal disease.Seminars in Dialysis, 1998, 11: 95-101.
  • 4Nygard O, Norderhaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 1997, 337: 230-236.
  • 5Bostom AG, Lathrop L. Hyperhomocysteinemia in end- stage renal disease: prevalence, etiology, and potential relationship to artherosclerotic outcomes. Kidney Int, 1997, 52: 10-20.
  • 6Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998,32 Suppl 3: 112-119.
  • 7Yu HH, Joubran R, Asmi M, et al. Agreement among four homocysteine assays and results in patients with coronaryatherosclerosis and controls. Clin Chem, 2000, 46: 258-264.
  • 8Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron, 1995, 70: 62-67.
  • 9Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephron, 1999, 10: 891-900.
  • 10Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation, 1998, 97: 138-141.

共引文献91

同被引文献7

  • 1ACC/AHA Guidelines for the evaluation and management of chronic heart failure. Circulation, 2001,104:2996-3007.
  • 2Guidelines for the diagnosis and treatment of chronic heart failure; task force for the diagnosis and treatment of chronic heart failure. Eur Heart, 2001,22:1527 -1560.
  • 3Rennison JH, McElfresh TA, Okere IC, et al. High-fat diet post infarction enhances mitochondrial f unction and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol, 2007,292 ( 3 ) : 1498 - 1506.
  • 4Chess DJ, Lei B, Hoit BD, et al. Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload. Am-J-Physiol-Heart-Circ-Physiol, 2007, 293 ( 3 ) : 1853-1860.
  • 5Lorgeril M, Salen P. Selenium and antioxidant defenses as major mediators in the development of chronic heart failure. Heart Fail Rev, 2006,11(1) :13-17.
  • 6王静,陈卫东,常保超.慢性肾衰竭患者同型半胱氨酸与心脑血管疾病的关系[J].中华全科医学,2008,6(10):996-997. 被引量:10
  • 7郑约楠,李素蘋,胡小明.各期慢性肾脏病患者的高同型半胱氨酸血症分析[J].中国现代医生,2010,48(32):21-21. 被引量:4

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部